Ondas
ONDS
$5.73
+2.87%
Ondas Inc. is a technology company operating in the communication equipment and autonomous systems space, designing and selling FullMAX Software Defined Radio (SDR) technology through its Ondas Networks segment and, more importantly, drone-based autonomous systems through Ondas Autonomous Systems, anchored by its Optimus platform and related support, maintenance, and ancillary services. The company is a small-cap, defense- and critical-infrastructure-oriented niche player rather than a scaled platform, with a market capitalization of roughly $2.2-3.3 billion, only 495 employees, and a revenue base that remains modest relative to its valuation. The current investor narrative is dominated by a violent tension between order momentum and profitability: management has secured large military and counter-drone orders (including a reported $70 million order tranche) and is pursuing bolt-on M&A such as the $125 million Cyberhawk acquisition to build recurring revenue, while sell-side coverage remains uniformly bullish on the back of a growing backlog. At the same time, the stock has de-rated sharply as investors question whether order flow can be converted into sustainable profit, with the upcoming Q3 report framed by the press as a critical test and profitability not expected until roughly 2029, leaving the equity hostage to contract headlines, government drone-procurement policy, and competitive pressure from larger players like Motorola's counter-drone buildout.…
ONDS
Ondas
$5.73
Related headlines
Investment Opinion: Should I buy ONDS Today?
Rating: Hold (speculative, position-sized). The core thesis is that Ondas has genuine order momentum — a reported $70M order tranche, revenue roughly tripling from $30.11M in Q4 2025 to $83.77M in Q2 2026, and a $666.4M cash pile with 0.0286 debt-to-equity — but the equity at $5.97 already discounts a successful conversion story at 42.67x P/S while burning $170.6M of trailing free cash flow and not expected to reach profitability until roughly 2029. The unanimous 10-for-10 Buy consensus with an $18.875 average target (+216% implied upside) is directionally supportive but looks stale after a 45.83% YTD decline, so it should be treated as a ceiling of sell-side hope rather than a near-term price anchor.
Supporting evidence is mixed but tilts toward patience over aggression. On the positive side, gross margin has improved from 25.8% in Q3 2025 to 43.1% in Q2 2026 (39.7% trailing), the current ratio of 4.84 and near-zero leverage remove solvency risk, and the P/S multiple has compressed roughly 78% from 198.70x in Q3 2025 to 42.67x today even as the revenue denominator grew — meaning the de-rating is partly arithmetic, not purely deterioration. Against that, Q2 2026 net income was -$88.25M on a -105.3% net margin, SG&A of $148.89M consumed $36.13M of gross profit more than four times over, shares outstanding rose from 380.8M to 500.7M in two quarters, and the consensus ~$2.03B revenue estimate implies a step-up that is not yet visible in reported results. EV/Sales of 9.80x is the more defensible lens given the net cash, but it still embeds years of flawless execution.
Three risks could invalidate even a Hold: (1) Q3 order conversion disappoints and the ~$2.03B consensus revenue bar is marked down, (2) continued equity issuance dilutes per-share value faster than revenue scales, and (3) Motorola's D-Fend counter-drone acquisition pressures a 495-employee niche player in its core military/critical-infrastructure end markets. This Hold would upgrade to Buy on evidence of operating leverage — specifically gross margin holding above 40% while quarterly revenue sustains above $80M and operating cash burn narrows below roughly -$50M — or if the stock retests the $4.375 52-week low with the order backlog intact. It would downgrade to Sell on a decisive break below $4.375, a revenue miss versus the consensus trajectory, or a fresh large equity raise at distressed prices. Valuation verdict: fairly valued to modestly expensive on EV/Sales relative to a pre-profit defense-electronics peer set, but cheap relative to its own one-year history — a stock priced for execution, not for safety.
Sign up to view all
ONDS 12-Month Price Forecast
The forward view is genuinely two-sided: the operating trajectory is improving fast (revenue tripling over two quarters, gross margin up 17 points, a fortress balance sheet), but the equity has already surrendered 60.9% from its high and still trades at 42.67x sales with negative free cash flow and a 2029 profitability horizon. The 55% base-case weight reflects that the most likely outcome is a volatile range between $4.375 and $9.00 while the market waits for proof that orders convert into margin leverage, with the 20% bull case requiring Q3 execution that validates the sell-side's $13-19 range. I would upgrade to bullish on a Q3 print showing revenue above $80M, gross margin above 40%, and operating cash burn narrowing below roughly -$50M, or on a retest of $4.375 with the backlog intact. I would downgrade to bearish on a decisive break below $4.375, a revenue miss versus the consensus trajectory, or a large equity raise at distressed prices.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ondas's 12-month outlook, with a consensus price target around $18.88 and implied upside of +229.4% versus the current price.
Average Target
$18.88
10 analysts
Implied Upside
+229.4%
vs. current price
Analyst Count
10
covering this stock
Price Range
$13 - $25
Analyst target range
Coverage is unusually broad and uniformly bullish for a company of this size: 10 analysts cover ONDS with 10 Buy ratings, 0 Hold, and 0 Sell, producing a consensus recommendation of "strong_buy" and a recommendation mean of 1.3 (where 1.0 is a strong buy). The average target price is $18.875, which against the current $5.97 implies approximately +216% upside, a spread so wide that it signals the sell-side is valuing the stock on backlog, contract pipeline, and long-dated earnings rather than near-term fundamentals. The consensus is therefore maximally bullish in direction but should be read with caution, because a 10-for-10 Buy ratio with zero holds is a pattern that often reflects relationship-driven coverage and stale targets rather than fresh conviction.
The target range runs from a low of $13.00 to a high of $25.00, meaning even the most conservative analyst sees roughly +118% upside from $5.97, while the high target implies +319% and would require a combination of multiple re-expansion toward prior peak sales multiples, successful integration of the Cyberhawk acquisition, and conversion of the reported $70 million order tranche and broader military backlog into recognized revenue. The low target of $13.00 still assumes substantial growth and some margin improvement, so the entire range is priced for a successful execution scenario; the risk is that the range is stale relative to the 45.83% YTD decline, and the institutional ratings history shows only reiterations (Needham Buy on 2026-09-14, Ladenburg Buy on 2026-08-17, Oppenheimer Outperform on 2026-08-14) with no downgrades but also no fresh initiations or target raises since the stock's collapse. The wide $12 spread between low and high targets signals high uncertainty, and with the stock trading 60.9% below its 52-week high while targets sit 118-319% above the current price, the gap between sell-side expectations and market pricing is the single most important thing to monitor into the Q3 earnings report.
Bulls vs Bears: ONDS Investment Factors
The bear case currently carries stronger near-term evidence: ONDS is deeply unprofitable (-$88.25M Q2 net income, -194.5% operating margin), burning $170.6M of trailing free cash flow, diluting shareholders aggressively (380.8M to 500.7M shares in two quarters), and trading in a confirmed downtrend 60.9% below its high with a -67.74% max drawdown. The bull case rests on genuine order momentum (a $70M tranche, revenue tripling from $30.11M to $83.77M over two quarters), a fortress balance sheet ($666.4M cash, 0.0286 D/E), a P/S multiple compressed 78% from peak, and unanimous sell-side support with a $18.875 average target. The single most important tension is conversion: whether the reported backlog and military orders translate into recognized revenue and margin leverage fast enough to justify a 42.67x P/S before the cash pile and shareholder patience run out. If Q3 shows revenue scaling into the fixed cost base, the de-rating looks overdone; if orders slip or margins stall, the falling-knife dynamic resumes toward the $4.375 low.
Bullish
- Unanimous Strong Buy Coverage, +216% Target: All 10 covering analysts rate ONDS a Buy (0 Hold, 0 Sell) with a recommendation mean of 1.3 and an average target of $18.875 versus the $5.97 price — roughly +216% implied upside. Even the lowest target of $13.00 implies +118%, so the entire sell-side range sits far above current pricing.
- Revenue Tripling Over Two Quarters: Revenue rose from $30.11M in Q4 2025 to $50.12M in Q1 2026 to $83.77M in Q2 2026, with Q2 up 12.35% year-over-year against a $6.27M base. Product revenue of $422.4M dwarfs development revenue of $98.1M, confirming the Optimus drone platform is the growth engine.
- Fortress Balance Sheet, Near-Zero Leverage: Cash of $666.4M, a current ratio of 4.84, and debt-to-equity of just 0.0286 mean there is essentially no solvency risk. The company can fund its burn and bolt-on M&A (e.g., the $125M Cyberhawk deal) without distress, unlike most pre-profit small caps.
- P/S Compressed 78% From Peak: The price-to-sales multiple has fallen from 198.70x in Q3 2025 to 80.28x, 49.25x, and now 42.67x, while the revenue denominator grew rapidly. The stock is cheaper on sales than at any point in the past year, and EV/Sales of 9.80x is far more defensible given the net cash pile.
Bearish
- Deeply Unprofitable With 2029 Timeline: Q2 2026 net income was -$88.25M on a -105.3% net margin, with an operating margin of -194.5% and SG&A of $148.89M against just $36.13M of gross profit. Press commentary points to profitability not arriving until roughly 2029, so the equity is a long-dated bet on earnings that do not exist today.
- Severe Cash Burn and Heavy Dilution: Trailing free cash flow is -$170.6M and Q2 2026 FCF was -$93.8M, while stock-based compensation of $69.1M in the quarter is a large non-cash drag. Shares outstanding ballooned from 380.8M at Q4 2025 to 500.7M at Q2 2026, and growth is funded by equity issuance ($969.1M of common stock in Q1 2026) rather than internal cash.
- 42.67x P/S Prices In Flawless Execution: A 42.67x price-to-sales and 4.95x price-to-book against a 39.7% gross margin and -260.2% net margin is a story premium, not a profitability premium. The consensus revenue estimate of ~$2.03B implies an enormous step-up from the current run-rate, leaving little room for error.
- Brutal Downtrend, -67.74% Max Drawdown: ONDS is down 45.83% YTD and 38.71% over three months, sitting 60.9% below its $15.28 high and only 14.6% above its $4.375 low. Three-month relative strength of -36.39% versus SPY shows more than 36 points of underperformance in a single quarter, and the -67.74% max drawdown confirms a post-parabolic collapse.
ONDS Technical Analysis
ONDS is in a pronounced, sustained downtrend despite a marginally positive 1-year price change of +2.75%, a figure that masks a brutal path: the stock is down 45.83% year-to-date and 32.62% over six months, and at $5.97 it sits just 14.6% above its 52-week low of $4.375 and a full 60.9% below its 52-week high of $15.28. In range terms, the stock is trading at approximately 14.6% of its 52-week range, a positioning that typically signals either deep-value accumulation or a falling knife, and given the sequence of lower highs and lower lows since the May peak near $13.58, the weight of evidence favors the latter until a base forms. The maximum drawdown of -67.74% confirms this is a post-parabolic collapse rather than an orderly correction, and the 1-year return of +2.75% versus SPY's +12.18% (relative strength of -9.43%) shows the stock has surrendered essentially all of its prior outperformance.
Short-term momentum is decisively negative and decelerating relative to the longer-term trend: the stock is down 11.29% over the past month and 38.71% over three months, with three-month relative strength of -36.39% versus SPY's -2.32%, meaning the stock has underperformed the market by more than 36 percentage points in a single quarter. The one-month decline of 11.29% is actually an improvement over the three-month collapse, suggesting the pace of selling is moderating, and the most recent session printed a sharp +11.90% bounce (from a $5.335 previous close to $5.97) on elevated volume of 47.6 million shares, which is consistent with capitulation-style selling followed by short-covering rather than a confirmed trend reversal. The 1-month relative strength of -7.97% versus SPY's -3.32% still shows underperformance, so the bounce must be treated as a counter-trend move within a downtrend until price reclaims the $7.00-7.50 area where the September-October consolidation broke down. Notably, the short ratio of 4.11 days-to-cover indicates meaningful short interest that can amplify both rallies and further declines.
Key technical levels are clearly defined: support sits at the 52-week low of $4.375, with the recent intraday capitulation low near $4.52 (November 5 close) acting as the immediate floor, while resistance is layered at the $7.00-7.50 breakdown zone and then the 52-week high of $15.28. A decisive break below $4.375 would signal a fresh leg lower and likely trigger momentum-driven selling, whereas a reclaim of $7.50 would be the first evidence of a durable bottom and open the path toward the $9-10 region where the August distribution occurred. Volatility is extreme: the beta of 3.082 means the stock is roughly three times as volatile as the S&P 500, so a 1% market move implies a ~3% move here, which demands materially smaller position sizing and wider stops; combined with the -67.74% max drawdown, this is a high-risk instrument where risk management, not conviction, determines outcomes.
Beta
3.08
3.08x market volatility
Max Drawdown
-67.7%
Largest decline past year
52-Week Range
$4-$15
Price range past year
Annual Return
-1.2%
Cumulative gain past year
| Period | ONDS Return | S&P 500 |
|---|---|---|
| 1m | -14.1% | -2.4% |
| 3m | -35.7% | -2.3% |
| 6m | -46.0% | +2.8% |
| 1y | -1.2% | +11.3% |
| ytd | -48.0% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ONDS Fundamental Analysis
Revenue is growing rapidly but from a very small base and with uneven quarterly cadence: Q2 2026 revenue was $83.77 million, up 12.35% year-over-year versus Q2 2025's $6.27 million, a comparison that reflects both organic drone demand and acquisitions, while the sequential step-up from Q1 2026's $50.12 million and Q4 2025's $30.11 million shows the top line roughly tripling over two quarters. The segment mix is dominated by product revenue ($422,413 thousand) versus development revenue ($98,051 thousand), confirming that Ondas Autonomous Systems and hardware sales, not the legacy FullMAX radio business, are the growth engine. However, the growth is lumpy and contract-dependent, and the consensus revenue estimate of approximately $2.03 billion (average) implies an enormous step-up from the current run-rate, a bar that leaves little room for execution error and makes the Q3 print a binary catalyst.
Profitability remains deeply negative and, on a GAAP basis, erratic: Q2 2026 net income was -$88.25 million with a net margin of -105.3%, gross margin of 43.13%, and operating margin of -194.5%, while Q1 2026 showed a bizarre +$362.95 million net profit driven almost entirely by a $404.2 million non-operating "other income" item rather than operations, which had an operating loss of -$42.67 million. Gross margin has been volatile but generally improving from the 25.8% recorded in Q3 2025 to 43.1% in Q2 2026, and the trailing gross margin of 39.7% is respectable for a hardware-heavy defense supplier, but operating expenses are consuming it many times over: Q2 2026 SG&A alone was $148.89 million against $36.13 million of gross profit, and R&D of $30.95 million plus $128.01 million of G&A reflect a cost structure built for a much larger company. The path to profitability is therefore long and dependent on revenue scaling into that fixed cost base, consistent with press commentary that profitability may not arrive until 2029.
Balance-sheet strength is the company's principal financial asset: the current ratio is 4.84, cash at the end of Q2 2026 was $666.4 million (down from $1.04 billion as cash was deployed into $314.8 million of investment purchases and $13.5 million of acquisitions), and debt-to-equity is a negligible 0.0286, so there is essentially no leverage risk. The problem is cash burn: trailing free cash flow is -$170.6 million, Q2 2026 free cash flow was -$93.8 million with operating cash flow of -$86.1 million, and stock-based compensation of $69.1 million in the quarter is a large non-cash drag that also signals dilution pressure (shares outstanding rose from 380.8 million at Q4 2025 to 500.7 million at Q2 2026). ROE of -30.19% and ROA of -8.37% confirm that capital is being consumed rather than compounded, and the company is funding growth through equity issuance (Q1 2026 common stock issued of $969.1 million) rather than internal cash generation, which is sustainable only as long as the market is willing to fund the story.
Quarterly Revenue
$83772000.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
43.1%
Latest Quarter
Free Cash Flow
$-170628649.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ONDS Overvalued?
Because trailing net income is negative (EPS of -$0.061, trailing PE of -15.74, forward PE of -298.5), the PE ratio is not meaningful and I am leading with the price-to-sales ratio, which at 42.67x is the only multiple that can be applied to a pre-profit, high-growth defense/autonomy story; the EV/Sales ratio of 9.80x is far lower than the 42.67x P/S, a gap explained by the large cash pile and investments on the balance sheet being netted out of enterprise value. The negative forward PE of -298.5 versus the trailing -15.74 implies the market expects losses to narrow dramatically, and the consensus forward EPS estimate of $0.51 (average) versus the trailing -$0.061 shows analysts are modeling a swing to profitability that is not yet visible in reported results, so the valuation is effectively a bet on 2027-2029 earnings that do not exist today.
Peer comparison is difficult because the provided valuation dataset does not include an industry-average multiple, but the absolute levels are extreme for a communication equipment/defense hardware company: a 42.67x P/S and 4.95x price-to-book against a gross margin of 39.7% and a net margin of -260.2% (trailing) is a growth-and-story premium, not a profitability premium, and the PEG ratio of -9.60 is meaningless given negative earnings. The 9.80x EV/Sales is more defensible for a company with triple-digit revenue growth and a large net cash position, but it still embeds years of flawless execution; any peer set of profitable defense-electronics names would trade at a fraction of 42.67x sales, so the premium is justified only if Ondas converts its backlog into revenue at the pace the consensus $2.03 billion estimate assumes.
Historically, Ondas has almost always traded at elevated sales multiples, but the current 42.67x P/S is near the low end of its own recent band: the historical P/S ratio was 49.25x in Q2 2026, 80.28x in Q1 2026, 123.42x in Q4 2025, and 198.70x in Q3 2025, so the multiple has compressed by roughly 78% from its Q3 2025 peak even as the share price fell. That compression reflects both the collapse in price and the rapid growth in the revenue denominator, and it means the stock is cheaper on sales than it has been at any point in the past year; the price-to-book of 4.95x versus 2.63x in Q2 2026 and 8.50x in Q4 2025 similarly sits in the middle of its range. The interpretation is nuanced: the de-rating from 198.7x to 42.7x P/S suggests the market has already priced in substantial fundamental deterioration and dilution, so further downside may require an outright revenue miss, while a re-rating toward even 60-70x sales would imply meaningful upside if execution holds.
PE
-15.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
33.6x
Industry PE ~33.6x*
EV/EBITDA
-13.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are dominated by cash consumption and dilution rather than solvency. Trailing free cash flow is -$170.6M and Q2 2026 FCF was -$93.8M, with stock-based compensation of $69.1M in the quarter, while shares outstanding rose from 380.8M at Q4 2025 to 500.7M at Q2 2026 and Q1 2026 saw $969.1M of common stock issued. Revenue is lumpy and contract-dependent — Q2 2026's $83.77M was up 12.35% year-over-year but the consensus ~$2.03B estimate requires an enormous step-up — and the cost structure (Q2 SG&A of $148.89M, R&D of $30.95M, G&A of $128.01M) is built for a far larger company, so profitability may not arrive until roughly 2029. The $666.4M cash pile and 0.0286 debt-to-equity provide a multi-year runway, but continued equity funding depends on the market's willingness to finance the story.
Market and competitive risks center on valuation compression and a powerful new rival. At 42.67x P/S and 4.95x P/B against a 39.7% gross margin and -260.2% net margin, ONDS trades at a growth-and-story premium that any profitable defense-electronics peer set would dwarf on the downside; a beta of 3.082 means a 1% S&P move implies roughly a 3% move here, amplifying sector rotation. Motorola's D-Fend counter-drone acquisition (October 2026) strengthens a much larger competitor with existing customer relationships, and government drone-procurement policy — including potential direct US stakes in domestic drone makers — is a double-edged catalyst that can reverse sentiment quickly. The 10-for-10 Buy consensus with no fresh initiations or target raises since the collapse raises the risk that the $18.875 average target is stale relative to the 45.83% YTD decline.
Worst-case scenario: Q3 disappoints on order conversion or margin, the ~$2.03B consensus revenue bar proves unreachable, and the market re-prices the equity toward the 52-week low of $4.375 — a decline of roughly -27% from $5.97 — or below if momentum selling and the 4.11-day short ratio amplify the move. A more severe path, where the cash pile is further depleted by dilution and the multiple compresses toward the low end of its historical band, could revisit the -67.74% max drawdown trajectory and push the stock into the $3-4 range, a loss of roughly -33% to -50% from current levels. The recent intraday capitulation low near $4.52 (November 5 close) is the immediate floor to watch; a decisive break below $4.375 would signal a fresh leg lower.
FAQ
Ranked by severity, the first risk is financial: trailing free cash flow of -$170.6M and Q2 free cash flow of -$93.8M against a $666.4M cash pile, with shares outstanding rising from 380.8M to 500.7M in two quarters and $969.1M of common stock issued in Q1 2026 — continued equity funding at depressed prices would dilute per-share value faster than revenue scales. Second is company-specific execution: Q2 revenue of $83.77M must scale toward a ~$2.03B consensus estimate while SG&A of $148.89M consumed $36.13M of gross profit more than four times over, and profitability is not expected until roughly 2029. Third is competitive: Motorola's D-Fend counter-drone acquisition (October 2026) pits a 495-employee niche player against a far larger rival with existing customer relationships in its core military and critical-infrastructure markets. Fourth is macro and market-structure: a beta of 3.082 means roughly three times S&P 500 volatility, the 4.11-day short ratio amplifies both rallies and declines, and the stock has already suffered a -67.74% max drawdown with three-month relative strength of -36.39% versus SPY. Layered on top is the risk that the 10-for-10 Buy consensus and $18.875 average target are stale after a 45.83% YTD decline, leaving no fresh analyst support to cushion a disappointment.
The three-scenario framework assigns a 55% probability to the base case of $6.50-$9.00, a 25% probability to the bear case of $3.50-$4.375, and a 20% probability to the bull case of $13.00-$18.875. The base case is most likely: revenue keeps growing sequentially but lands below the ~$2.03B consensus, gross margin holds in the high-30s to low-40s percent, cash burn moderates from -$93.8M per quarter, and the multiple stabilizes in a 35-50x P/S band while the stock grinds between the $4.375 low and the $7.00-$7.50 breakdown zone. The bear case requires a Q3 revenue or margin miss that triggers downgrades and a re-pricing toward the 52-week low, amplified by the 4.11-day short ratio and beta of 3.082. The bull case requires the reported $70M order tranche and military backlog to convert into recognized revenue at scale with gross margin above 40%, which would re-rate the equity toward the 60-70x sales band and make the sell-side's $13.00 low target — roughly +118% from $5.97 — credible. The key assumption behind the base case is that order conversion is real but slower than the sell-side assumes.
ONDS cannot be valued on earnings — trailing EPS is -$0.061, trailing PE is -15.74, forward PE is -298.5, and the PEG of -9.60 is meaningless — so price-to-sales is the operative lens, and at 42.67x it is a story premium rather than a profitability premium. The more defensible metric is EV/Sales of 9.80x, which nets out the $666.4M cash pile and is reasonable for a company growing revenue triple digits, but it still embeds years of flawless execution against a 39.7% trailing gross margin and -260.2% net margin. Relative to its own history the stock is cheap: P/S has compressed from 198.70x in Q3 2025 to 80.28x, 49.25x, and now 42.67x, a roughly 78% de-rating even as the revenue denominator grew, and price-to-book of 4.95x sits mid-range versus 2.63x in Q2 2026 and 8.50x in Q4 2025. The market is therefore paying a premium to any profitable defense-electronics peer but a discount to Ondas's own recent past, implying it expects the ~$2.03B consensus revenue estimate to be substantially missed or delayed rather than achieved on schedule. Verdict: fairly valued to modestly expensive on EV/Sales, cheap versus its own history, and priced for execution rather than safety.
From a pure risk/reward standpoint the setup is asymmetric but not favorable enough to call it a straightforward buy: the $18.875 average analyst target implies roughly +216% upside from $5.97, yet the stock is 60.9% below its $15.28 high and only 14.6% above its $4.375 low, so the realistic near-term downside to that low is about -27%. The fundamental case is genuinely improving — revenue tripled from $30.11M in Q4 2025 to $83.77M in Q2 2026 and gross margin rose from 25.8% to 43.1% — but the company still lost $88.25M in Q2, burned $170.6M of trailing free cash flow, and trades at 42.67x sales with profitability not expected until roughly 2029. The biggest downside risk is a Q3 order-conversion miss that forces the ~$2.03B consensus revenue bar to be marked down, which with a 4.11-day short ratio and beta of 3.082 could accelerate selling below $4.375. It is a reasonable buy only for risk-tolerant investors who size it as a small speculative position and can tolerate a multi-year wait, and it becomes a much better buy if Q3 shows revenue above $80M with gross margin above 40% and cash burn narrowing below roughly -$50M.
ONDS is structurally a long-term speculative holding, not a trading vehicle for most investors, because the earnings visibility required to support the 42.67x P/S multiple does not exist until roughly 2029 and the company pays no dividend (payout ratio of 0, dividend yield of 0). The growth stage is early-commercial — revenue tripled from $30.11M to $83.77M over two quarters but from a tiny base, with lumpy contract-driven recognition and a cost structure (Q2 SG&A of $148.89M) built for a much larger company. Volatility is extreme: beta of 3.082, a -67.74% max drawdown, a 45.83% YTD decline, and a 4.11-day short ratio mean short-term price action is dominated by momentum and headlines rather than fundamentals, so traders would need wide stops and small size. A concrete suggested minimum holding period is 24-36 months, long enough to span several quarterly order-conversion prints and the 2027-2029 profitability window, and even then only as a position-sized allocation within a diversified portfolio. Investors unwilling to tolerate a retest of $4.375 — roughly -27% from $5.97 — should not hold it at all.